Lawmakers contemplate the return of mental health institutions in response to the drug crisis; new measures to rein in insulin prices take effect; FDA intensifies efforts to curb the teen vaping epidemic.
Congress is deliberating the revival of mental hospitals as a response to the escalating drug crisis, according to Politico. The proposal, while aiming to provide comprehensive care for individuals struggling with substance use disorders and mental health issues, has generated significant controversy. Supporters argue for a holistic approach, while critics express concerns about potential stigmatization and the need for more nuanced solutions in addressing the complex intersection of mental health and drug addiction.
In response to growing concerns over rising insulin prices, major insulin manufacturers, including Sanofi, Novo Nordisk, and Eli Lilly, have initiated measures added price caps and have made substantial reductions in list prices, which took effect on January 1, according to CNN. Sanofi has instituted a $35 monthly cap on out-of-pocket costs for its most widely prescribed insulin in the United States, following Novo Nordisk and Eli Lilly, which placed insulin caps on their products in 2023. The moves should make insulin more affordable for the 8.4 million Americans dependent on the life-saving medication, coming in response to mounting public pressure, changes in Medicaid rebate programs, and the entry of new competitors.
The FDA's recent crackdown on the importation of Elf Bar, a widely popular e-cigarette brand, is indicative of an escalated campaign against teen vaping, although thousands of other flavored e-cigarettes continue to make their way into the nation, according to The Associated Press. As health authorities grapple with the rising rates of youth nicotine addiction, the efforts to seize shipments of e-cigarettes are both applauded for their potential impact on public health and criticized for potential unintended consequences. The move underscores the ongoing challenge of balancing access for adult smokers seeking harm reduction with the imperative to protect younger generations from the dangers of nicotine addiction.
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More